Cognizant to roll out promotions for employees this week

The promotions announced are for employees up to associate level, effective October 1. Promotions to senior associate level and above will be announced in January-March 2021 quarter, effective January 1 2021.

Swathi Moorthy

November 10, 2020 / 22:26 IST

Cognizant will start rolling out promotions for employees this week effective October 1, 2020. The promotions announced are for employees up to the associate level.

Promotions for senior employees will be announced in January-March 2021 quarter, the company said in an email to employees.

In an email to employees, Becky Schmitt, Chief People Officer, Cognizant, said, “I’m very pleased to share that we are awarding promotions this week for associates moving up to Programmer Analyst through the Associate level, all effective October 1.”

“Promotions into Senior Associate to Vice President level roles will be announced in Q1 2021, effective January 1, 2021. Promoted associates will be notified by their managers,” the mail added.

The first set of employees getting promotions now typically have few years of experience. For instance, an associate could have anywhere between 3-7 years of experience, pointed out an employee. A senior associate and above have significant experience in the field and have more responsibilities.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show